Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Aurora Biosciences (ABSC) -- Ignore unavailable to you. Want to Upgrade?

To: jef saunders who wrote (273)	1/25/2000 9:31:00 PM
From: Richaaard	Respond to of 359

ABSC isn't a biotech, it's a bioinformatic. I can't advise you on what to do. Please do your own due diligence. Good luck

To: jef saunders who wrote (273)	1/26/2000 1:11:00 AM
From: Larry Liebman	Read Replies (1) \| Respond to of 359

Jeff, I agree with you that ABSC is a company to consider. OTOH, what I've learned through the '90's is that diversifying is a sign of intelligence and wisdom. With $3000., I'm willing to suggest you investigate a mutual fund while doing some due diligence. Best of luck.

To: jef saunders who wrote (273)	1/27/2000 11:40:00 AM
From: tuck	Read Replies (1) \| Respond to of 359

jef, I'd recommend the mutual fund. If you don't have some experience in biotech, lack of diversity will usually get you before you find the big winner. It is hard to say if ABSC is fairly valued at these levels. I sold the last of my position at 40 and am looking for the 20s to reenter. Whether or not I get that chance depends on earnings. Speaking of which: earningswhispers.com These guys rarely have reliable release dates, though; they're usually arrived at by adding 3 months to the previous release. Cheers, Tuck